BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31845794)

  • 1. Novel HDAC6 Inhibitors Increase Tubulin Acetylation and Rescue Axonal Transport of Mitochondria in a Model of Charcot-Marie-Tooth Type 2F.
    Adalbert R; Kaieda A; Antoniou C; Loreto A; Yang X; Gilley J; Hoshino T; Uga K; Makhija MT; Coleman MP
    ACS Chem Neurosci; 2020 Feb; 11(3):258-267. PubMed ID: 31845794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.
    Shen S; Benoy V; Bergman JA; Kalin JH; Frojuello M; Vistoli G; Haeck W; Van Den Bosch L; Kozikowski AP
    ACS Chem Neurosci; 2016 Feb; 7(2):240-58. PubMed ID: 26599234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease.
    d'Ydewalle C; Krishnan J; Chiheb DM; Van Damme P; Irobi J; Kozikowski AP; Vanden Berghe P; Timmerman V; Robberecht W; Van Den Bosch L
    Nat Med; 2011 Jul; 17(8):968-74. PubMed ID: 21785432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.
    Benoy V; Vanden Berghe P; Jarpe M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurotherapeutics; 2017 Apr; 14(2):417-428. PubMed ID: 27957719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice.
    Picci C; Wong VSC; Costa CJ; McKinnon MC; Goldberg DC; Swift M; Alam NM; Prusky GT; Shen S; Kozikowski AP; Willis DE; Langley B
    Exp Neurol; 2020 Jun; 328():113281. PubMed ID: 32147437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
    Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
    Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
    Çetin Ö; Sari S; Erdem-Yurter H; Bora G
    Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
    Gold WA; Lacina TA; Cantrill LC; Christodoulou J
    J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
    Asthana J; Kapoor S; Mohan R; Panda D
    J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth.
    Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L
    Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons.
    Kim C; Choi H; Jung ES; Lee W; Oh S; Jeon NL; Mook-Jung I
    PLoS One; 2012; 7(8):e42983. PubMed ID: 22937007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
    Shen S; Picci C; Ustinova K; Benoy V; Kutil Z; Zhang G; Tavares MT; Pavlíček J; Zimprich CA; Robers MB; Van Den Bosch L; Bařinka C; Langley B; Kozikowski AP
    J Med Chem; 2021 Apr; 64(8):4810-4840. PubMed ID: 33830764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6 regulates mitochondrial transport in hippocampal neurons.
    Chen S; Owens GC; Makarenkova H; Edelman DB
    PLoS One; 2010 May; 5(5):e10848. PubMed ID: 20520769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT.
    Rossaert E; Van Den Bosch L
    Brain Res; 2020 Apr; 1733():146692. PubMed ID: 32006555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
    Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
    Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
    Yu J; Ma Z; Shetty S; Ma M; Fu J
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport.
    Choi H; Kim HJ; Kim J; Kim S; Yang J; Lee W; Park Y; Hyeon SJ; Lee DS; Ryu H; Chung J; Mook-Jung I
    Mol Neurodegener; 2017 Feb; 12(1):23. PubMed ID: 28241840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.